Terms: = Ovarian cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Treatment
87 results:
1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
2. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
Grunt TW; Wagner R; Ries A; Berghoff AS; Preusser M; Grusch M; Valent P
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214315
[TBL] [Abstract] [Full Text] [Related]
3. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
McFadden M; Singh SK; Kinnel B; Varambally S; Singh R
J Ovarian Res; 2023 Nov; 16(1):220. PubMed ID: 37990267
[TBL] [Abstract] [Full Text] [Related]
4. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing.
Namikawa T; Tanaka T; Utsunomiya M; Yokota K; Munekage M; Maeda H; Kitagawa H; Kurioka Y; Satake H; Kobayashi M; Hanazaki K; Seo S
Clin J Gastroenterol; 2024 Feb; 17(1):12-17. PubMed ID: 37934348
[TBL] [Abstract] [Full Text] [Related]
5. PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J; Hulse M; Sivakumar M; Burtell J; Thodima V; Wang M; Agarwal A; Vykuntam K; Spruance J; Bhagwat N; Rager J; Ruggeri B; Scherle P; Ito K
Cancer Res Commun; 2023 Nov; 3(11):2233-2243. PubMed ID: 37861290
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
7. FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest.
Pan Q; Wang Q; Zhao T; Zhao X; Liang Y; Shi M; Chen C; Lin F
Med Oncol; 2023 Jun; 40(8):215. PubMed ID: 37382687
[TBL] [Abstract] [Full Text] [Related]
8. Synergistic antitumor effect of folate-targeted Pluronic™ F-127/poly(lactic acid) polymersomes for codelivery of doxorubicin and paclitaxel.
Wu TY; Li ZL; Gong YC; Xiong XY
Nanomedicine (Lond); 2023 Feb; 18(5):455-469. PubMed ID: 37166001
[TBL] [Abstract] [Full Text] [Related]
9. Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Yuan M; Wu Q; Zhang M; Lai M; Chen W; Yang J; Jiang L; Cao J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):207-220. PubMed ID: 36915997
[TBL] [Abstract] [Full Text] [Related]
10. Germline cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations.
Liu Y; Gusev A; Kraft P
Cancer Res; 2023 Apr; 83(8):1191-1202. PubMed ID: 36745477
[TBL] [Abstract] [Full Text] [Related]
11. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract] [Full Text] [Related]
12. An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of ovarian cancer.
Song J; Ye H; Jiang S; Yang Y; Li X
Int J Nanomedicine; 2022; 17():4961-4974. PubMed ID: 36275480
[TBL] [Abstract] [Full Text] [Related]
13. Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with fanca mutation: A case report.
Lai YH; Tung KC; Chen SC
Medicine (Baltimore); 2022 Sep; 101(39):e30719. PubMed ID: 36181052
[TBL] [Abstract] [Full Text] [Related]
14. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
[TBL] [Abstract] [Full Text] [Related]
15. Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells.
Farhadi A; Homayouni Tabrizi M; Sadeghi S; Vala D; Khosravi T
J Biomater Sci Polym Ed; 2023 Feb; 34(3):315-333. PubMed ID: 36063019
[TBL] [Abstract] [Full Text] [Related]
16. Safe and efficient 2D molybdenum disulfide platform for cooperative imaging-guided photothermal-selective chemotherapy: A preclinical study.
Li X; Kong L; Hu W; Zhang C; Pich A; Shi X; Wang X; Xing L
J Adv Res; 2022 Mar; 37():255-266. PubMed ID: 35499043
[TBL] [Abstract] [Full Text] [Related]
17. Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in ovarian cancer.
Pan Y; Wang Z; Ma J; Zhou T; Wu Z; Ding P; Sun N; Liu L; Pei R; Zhu W
Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323454
[TBL] [Abstract] [Full Text] [Related]
18. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract] [Full Text] [Related]
19. THE QUALITY OF LIFE OF ovarian cancer PATIENTS AS AN INDICATION OF THE EFFECTIVENESS OF PLATINUM-BASED ADJUVANT CHEMOTHERAPY.
Bondar O; Rybin A; Patskov A; Varabina A
Georgian Med News; 2021 Nov; (320):32-36. PubMed ID: 34897041
[TBL] [Abstract] [Full Text] [Related]
20. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Fierheller CT; Guitton-Sert L; Alenezi WM; Revil T; Oros KK; Gao Y; Bedard K; Arcand SL; Serruya C; Behl S; Meunier L; Fleury H; Fewings E; Subramanian DN; Nadaf J; Bruce JP; Bell R; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Majewski J; Pugh TJ; Tischkowitz M; James PA; Campbell IG; Greenwood CMT; Ragoussis J; Masson JY; Tonin PN
Genome Med; 2021 Dec; 13(1):186. PubMed ID: 34861889
[TBL] [Abstract] [Full Text] [Related]
[Next]